![Recovery of taste organs and sensory function after severe loss from Hedgehog/Smoothened inhibition with cancer drug sonidegib | PNAS Recovery of taste organs and sensory function after severe loss from Hedgehog/Smoothened inhibition with cancer drug sonidegib | PNAS](https://www.pnas.org/cms/10.1073/pnas.1712881114/asset/c5892029-d1db-472f-9050-5b92b05702da/assets/graphic/pnas.1712881114fig01.jpeg)
Recovery of taste organs and sensory function after severe loss from Hedgehog/Smoothened inhibition with cancer drug sonidegib | PNAS
![Frontiers | Regulation of Hedgehog Signaling by miRNAs and Nanoformulations: A Possible Therapeutic Solution for Colorectal Cancer | Oncology Frontiers | Regulation of Hedgehog Signaling by miRNAs and Nanoformulations: A Possible Therapeutic Solution for Colorectal Cancer | Oncology](https://www.frontiersin.org/files/Articles/607607/fonc-10-607607-HTML/image_m/fonc-10-607607-g001.jpg)
Frontiers | Regulation of Hedgehog Signaling by miRNAs and Nanoformulations: A Possible Therapeutic Solution for Colorectal Cancer | Oncology
![Odomzo (sonidegib) for the Treatment of Locally Advanced Basal Cell Carcinoma - Clinical Trials Arena Odomzo (sonidegib) for the Treatment of Locally Advanced Basal Cell Carcinoma - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2019/07/1l-image-87.jpg)
Odomzo (sonidegib) for the Treatment of Locally Advanced Basal Cell Carcinoma - Clinical Trials Arena
![Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma. - Abstract - Europe PMC Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5028081/bin/ott-9-5671Fig1.jpg)
Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma. - Abstract - Europe PMC
![PDF] Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas | Semantic Scholar PDF] Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8e476a9c49780bf38ebb73175bec4b850d243f92/2-Figure1-1.png)
PDF] Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas | Semantic Scholar
![PDF] Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas | Semantic Scholar PDF] Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8e476a9c49780bf38ebb73175bec4b850d243f92/3-Figure2-1.png)
PDF] Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas | Semantic Scholar
![Targeted inhibition of Hedgehog-GLI signaling by novel acylguanidine derivatives inhibits melanoma cell growth by inducing replication stress and mitotic catastrophe | Cell Death & Disease Targeted inhibition of Hedgehog-GLI signaling by novel acylguanidine derivatives inhibits melanoma cell growth by inducing replication stress and mitotic catastrophe | Cell Death & Disease](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41419-017-0142-0/MediaObjects/41419_2017_142_Fig1_HTML.jpg)
Targeted inhibition of Hedgehog-GLI signaling by novel acylguanidine derivatives inhibits melanoma cell growth by inducing replication stress and mitotic catastrophe | Cell Death & Disease
![Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update | Future Oncology Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon-2016-0118/asset/images/medium/figure1.gif)
Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update | Future Oncology
![Vismodegib, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas - ScienceDirect Vismodegib, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1040842815300767-gr1.jpg)